BioSpace News Archive

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, announced today that registration is open for its two virtual survivorship conferences to be held this spring: HOPE Summit and COPE Summit

Mallinckrodt plc announced that it has reached agreement with an ad hoc group of first lien term lenders holding approximately $1.3 billion of its outstanding First Lien Term Loans to support the Company’s previously announced restructuring support agreement.

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, AIM’s Chief Executive Officer, has been invited to present at the Inaugural Emerging Growth Virtual Conference , presented by M Vest LLC and Maxim Group LLC. The conference will take place March 17-19, from 9:00 am to 5:00 pm ET,

Lannett Company, Inc. (NYSE: LCI) today announced that it recently received feedback from the U.S. Food and Drug Administration (FDA) regarding biosimilar insulin glargine, a product the company is co-developing with its strategic alliance partners within the HEC Group of companies (HEC).

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced seven presentations at ENDO 2021, the Endocrine Society’s annual meeting, taking place virtually from March 20-23, 2021.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that the Company has doubled its planned production volumes of its recombinant spider silk for the month of March.

Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), one of the largest multi-specialty healthcare systems in the United States, has been invited to participate at the 33 rd Annual ROTH Growth Conference being held virtually on March 15-17, 2021.

Revenue returns to pre-Covid19 levels on strong CRO/pharma sales Operating margin increased year-over-year on GAAP and an adjusted basis New debt facility significantly reduces annual interest expense

Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel

KSQ Therapeutics to Present at the Oppenheimer 31 st Annual Healthcare Conference